Overview Fundamentals API Earnings EOD API Sample Code Pricing

ZyVersa Therapeutics Inc. (ZVSA NASDAQ) stock market data APIs

$2.76 0.25(10%) as of September 6, 2024
Price chart is built with Anychart

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial to the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, IgA neuropathy, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity. ZyVersa Therapeutics, Inc. was founded in 2014 and is headquartered in Weston, Florida.

ZyVersa Therapeutics Inc. Financial Data Overview

2.51
2.76
-
2.765
2.5
2.5-79.8
2 583 K
0.002
1 029 K
0
-3.31
0.637
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ZVSA',
Type: 'Common Stock',
Name: 'ZyVersa Therapeutics Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01137LPK6',
ISIN: NULL,
CUSIP: NULL,
CIK: '1859007',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2022-12-12',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

ZyVersa Therapeutics Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -10 249 107
  • Earnings Per Share 1232.39
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get ZyVersa Therapeutics Inc. Earnings via APIs

  • Latest Release 2024-08-12
  • EPS/Forecast -3.75

Get ZyVersa Therapeutics Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com